Seeing Is Believing

Currently out of the existing stock ratings of Frank Sparacino, 6 are a BUY (75%), 1 are a SELL (12.5%), 1 are a HOLD (12.5%).
Analyst Frank Sparacino, carries an average stock price target met ratio of 55.56% that have a potential upside of 38.19% achieved within 350 days. Previously, Frank Sparacino worked at FIRST ANALYSIS.
Frank Sparacino’s has documented 17 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on HIIQ, Benefytt Technologies at 22-Mar-2019.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for TRHC (TABULA RASA HEALTHCARE) at 4/10/2018. The price target of $47 was fulfilled within 31 days with a profit of $7.84 (20.02%) receiving and performance score of 6.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Oct-2020
$28
$5.75 (25.84%)
$29
2 months 23 days ago
(17-Dec-2025)
12/13 (92.31%)
$4.18 (17.55%)
38
Hold Since 05-Jan-2017
$28
$5.75 (25.84%)
$22
4 years 7 months 13 days ago
(27-Jul-2021)
8/8 (100%)
$-1.26 (-4.31%)
179
$32
$9.75 (43.82%)
$30
7 years 8 months 1 days ago
(11-Jul-2018)
2/2 (100%)
$3.21 (11.15%)
1526
Hold Since 14-Jun-2018
$28
$5.75 (25.84%)
$35
7 years 8 months 26 days ago
(14-Jun-2018)
2/4 (50%)
$0.41 (1.49%)
321
Buy Since 01-Aug-2014
$26
8 years 4 months 15 days ago
(25-Oct-2017)
7/7 (100%)
$4.31 (19.87%)
1552
What Year was the first public recommendation made by Frank Sparacino?